Related Experiment Videos
Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease?
1Department of Psychiatry and Psychology and Alzheimer's Disease Research Center, Mayo Clinic, Rochester, MN 55905, USA. smith.glenn@mayo.edu
Abstract:
Mild cognitive impairment (MCI) is one label applied to cognitive dysfunction that is beyond normal aging but of insufficient magnitude to qualify for the diagnosis dementia. Various opinions exist about the proportion of people who fall in this boundary condition, the rate at which they will progress to a full dementia syndrome, and the nature and extent of cognitive impairment at the time of MCI diagnosis. There are at least four important dimensions along which studies of boundary conditions must be compared in order to understand the discrepant findings. The first is the population frame sampled to establish MCI cohorts. The second is the nature of memory complaints. The third and fourth respectively, are the type of memory assessment and number and type of other cognitive domains assessed to identify and follow these groups. The contributions of each of these dimensions to the diagnosis of MCI and it's outcome are discussed.
Insights
Mild cognitive impairment (MCI) involves cognitive issues beyond normal aging but not dementia. Understanding MCI progression requires comparing study dimensions like population, memory complaints, and cognitive assessments.
Area of Science:
- Neurology
- Gerontology
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia.
- Significant variability exists in understanding MCI's prevalence, progression rates, and diagnostic criteria.
- Discrepancies in MCI research findings stem from methodological differences.
Purpose of the Study:
- To analyze the key dimensions influencing Mild Cognitive Impairment (MCI) diagnosis and outcomes.
- To provide a framework for comparing diverse MCI studies and reconciling conflicting results.
- To elucidate the impact of sampling, complaint nature, and assessment methods on MCI characterization.
Main Methods:
- Comparative analysis of existing studies on Mild Cognitive Impairment (MCI).
- Identification and examination of four critical dimensions in MCI research: population, memory complaints, memory assessment, and other cognitive domains.
- Discussion of how these dimensions affect MCI diagnosis and prognosis.
Main Results:
- The definition and progression of MCI are highly dependent on the study's population frame.
- The nature of memory complaints significantly influences MCI identification and patient experience.
- Variations in memory assessment tools and the breadth of cognitive domains evaluated impact MCI classification and outcome prediction.
Conclusions:
- Standardizing the methodological dimensions is crucial for consistent MCI research.
- A comprehensive approach, considering multiple cognitive domains and assessment types, is necessary for accurate MCI diagnosis.
- Understanding these dimensions can improve the prediction of progression from MCI to dementia.